Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 149 No. 1314 (2019)

Screening strategy for Chagas disease in a non-endemic country (Switzerland): a prospective evaluation

DOI
https://doi.org/10.4414/smw.2019.20050
Cite this as:
Swiss Med Wkly. 2019;149:w20050
Published
04.04.2019

Abstract

The WHO recommends screening of Latin American migrants for Chagas disease to reduce morbidity and mortality and increase the likelihood of eradicating the disease. The objective was to assess the feasibility and acceptability of a screening strategy in one Swiss canton. From February 2011 to September 2012, people attending six healthcare centres of different types were offered a rapid diagnostic test if they or their mother were of Latin American origin (or, at the blood donation centre, if they had travelled for ≥1 year in Latin America). In addition, testing was offered during events where Latin Americans gathered. In total, 1,010 people were tested, mainly originating from Brazil (24%), Ecuador (13%) and Chile (10%). 54% were born in Latin America, 15% had a Latin American mother, and 29% were travellers. The prevalence of Chagas disease was 2.3% among migrants (15.5% in the community testing) and 0% among travellers. The prevalence was 18.0%, 0.8%, 0.5% and 0% among Bolivians, Ecuadorians, Brazilians and other countries respectively. Predictors for Chagas disease were: born in Latin America (OR = infinite, p <0.001), Bolivian origin (OR = 95, 95% CI: 19–482, p <0.001), being tested in the community (OR = 56, 95% CI: 14–218, p <0.001), and age >35 years OR = 3.4, 95% CI: 1.1–10.5, p = 0.03). The prevalence of Chagas disease was much higher in people attending social events than healthcare centres, suggesting that observations based only on health facility data underestimate the real prevalence of Chagas disease. Screening in the community was well accepted and should be promoted to reach the population at highest risk.

References

  1. Ramos JM, Milla A, Rodríguez JC, López-Chejade P, Flóres M, Rodríguez JM, et al. Chagas disease in Latin American pregnant immigrants: experience in a non-endemic country. Arch Gynecol Obstet. 2012;285(4):919–23. doi:.https://doi.org/10.1007/s00404-011-2081-9
  2. Muñoz J, Coll O, Juncosa T, Vergés M, del Pino M, Fumado V, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending 2 maternity clinics in Barcelona, Spain. Clin Infect Dis. 2009;48(12):1736–40.
  3. Paricio-Talayero JM, Benlloch-Muncharaz MJ, Collar-del-Castillo JI, Rubio-Soriano A, Serrat-Pérez C, Magraner-Egea J, et al. Vigilancia epidemiológica de la transmisión vertical de la enfermedad de Chagas en tres maternidades de la Comunidad Valenciana [Epidemiological surveillance of vertically-transmitted Chagas disease at three maternity hospitals in the Valencian Community]. Enferm Infecc Microbiol Clin. 2008;26(10):609–13. Article in Spanish.
  4. Jackson Y, Myers C, Diana A, Marti HP, Wolff H, Chappuis F, et al. Congenital transmission of Chagas disease in Latin American immigrants in Switzerland. Emerg Infect Dis. 2009;15(4):601–3.
  5. Piron M, Vergés M, Muñoz J, Casamitjana N, Sanz S, Maymó RM, et al. Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain). Transfusion. 2008;48(9):1862–8.
  6. Assal A, Corbi C. [Chagas disease and blood transfusion: an emerging issue in non-endemic countries]. Transfus Clin Biol. 2011;18(2):286–91. Article in French.
  7. Jackson Y, Gétaz L, Wolff H, Holst M, Mauris A, Tardin A, et al. Prevalence, clinical staging and risk for blood-borne transmission of Chagas disease among Latin American migrants in Geneva, Switzerland. PLoS Negl Trop Dis. 2010;4(2):e592.
  8. Custer B, Agapova M, Bruhn R, Cusick R, Kamel H, Tomasulo P, et al. Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi. Transfusion. 2012;52(9):1901–11.
  9. Kessler DA, Shi PA, Avecilla ST, Shaz BH. Results of lookback for Chagas disease since the inception of donor screening at New York Blood Center. Transfusion. 2013;53(5):1083–7.
  10. Queiros L, Neto S, Leal J, Carvalho C, Paula A, Couto MJ, et al. Estudo Epidemiologico da doença de Chagas em dadores de sangue. ABO. 2010;41:29–34. Article in Portuguese.
  11. World Health Organization (WHO). Statement – Chagas disease in Europe. Geneva: WHO; 2009. [Accessed: 8 Feb 2015]. Available from: http://www.who.int/neglected_diseases/integrated_media_chagas_statement/en/
  12. World Health Organization (WHO). Control and prevention of Chagas disease in Europe. Report of a WHO Informal Consultation. Geneva: WHO; 2009. [Accessed: 8 Feb 2015]. Available from: http://www.fac.org.ar/1/comites/chagas/Chagas_WHO_Technical%20Report_16_06_10.pdf.
  13. Roca C, Pinazo MJ, López-Chejade P, Bayó J, Posada E, López-Solana J, et al.; Chagas-Clot Research Group. Chagas disease among the Latin American adult population attending in a primary care center in Barcelona, Spain. PLoS Negl Trop Dis. 2011;5(4):e1135. doi:.https://doi.org/10.1371/journal.pntd.0001135
  14. Soriano Arandes A, Muñoz Gutierrez J, Vergés Navarro M, Castells Doménech C, Portús Vinyeta M, Gascón Brustenga J. Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain). Acta Trop. 2009;112(2):228–30. doi:.https://doi.org/10.1016/j.actatropica.2009.07.014
  15. Muñoz J, Gómez i Prat J, Gállego M, Gimeno F, Treviño B, López-Chejade P, et al. Clinical profile of Trypanosoma cruzi infection in a non-endemic setting: immigration and Chagas disease in Barcelona (Spain). Acta Trop. 2009;111(1):51–5. doi:.https://doi.org/10.1016/j.actatropica.2009.02.005
  16. Rodríguez-Guardado A, Rodríguez M, Alonso P, Seco C, Flores-Chavez M, Mejuto P, et al. Serological screening of Chagas disease in an immigrant population in Asturias, Spain proceeding from Chagas-endemic areas. Scand J Infect Dis. 2009;41(10):774–6.
  17. Ramos JM, Ponce Y, Gallegos I, Flóres-Chávez M, Cañavate C, Gutiérrez F. Trypanosoma cruzi infection in Elche (Spain): comparison of the seroprevalence in immigrants from Paraguay and Bolivia. Pathog Glob Health. 2012;106(2):102–6. doi:.https://doi.org/10.1179/2047773212Y.0000000013
  18. Navarro M, Perez-Ayala A, Guionnet A, Perez-Molina JA, Navaza B, Estevez L, et al. Targeted screening and health education for Chagas disease tailored to at-risk migrants in Spain, 2007 to 2010. Euro Surveill. 2011;16(38):19973. doi:.https://doi.org/10.2807/ese.16.38.19973-en
  19. Angheben A, Anselmi M, Gobbi F, Marocco S, Monteiro G, Buonfrate D, et al. Chagas disease in Italy: breaking an epidemiological silence. Euro Surveill. 2011;16(37):19969.
  20. Lescure F-X, Paris L, Elghouzzi MH, Le Loup G, Develoux M, Touafek F, et al. [Experience of targeted screening of Chagas disease in Ile-de-France]. Bull Soc Pathol Exot. 2009;102(5):295–9. Article in French.
  21. Steele LS, MacPherson DW, Kim J, Keystone JS, Gushulak BD. The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada. J Immigr Minor Health. 2007;9(1):43–7. doi:.https://doi.org/10.1007/s10903-006-9014-x
  22. Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, et al.; Working Group on Chagas Disease. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16(37):19968.
  23. Canton de vaud. Indicateurs démographiques de la population étrangère dans le canton de Vaud, Etat à la fin décembre 2011, Statistique Vaud 2012. [Accessed: 8 Feb 2015]. French. Available from: http://www.scris.vd.ch/default.aspx?docid=7405.
  24. Bolzman C, Carbajal M, Mainardi G. La Suisse au rythme latino: dynamiques migratoires des Latino-Américains : logiques d’action, vie quotidienne, pistes d’interventions dans les domaines du social et de la santé. Geneva, Switzerland: Haute école de travail social (Institut d’études sociales) ; 2007. In French.
  25. Chappuis F, Mauris A, Holst M, Albajar-Vinas P, Jannin J, Luquetti AO, et al. Validation of a rapid immunochromatographic assay for diagnosis of Trypanosoma cruzi infection among Latin-American Migrants in Geneva, Switzerland. J Clin Microbiol. 2010;48(8):2948–52. doi:.https://doi.org/10.1128/JCM.00774-10
  26. Otani MM, Vinelli E, Kirchhoff LV, del Pozo A, Sands A, Vercauteren G, et al. WHO comparative evaluation of serologic assays for Chagas disease. Transfusion. 2009;49(6):1076–82. doi:.https://doi.org/10.1111/j.1537-2995.2009.02107.x
  27. Gontijo ED, Rocha MO, Torquato de Oliveira U. Perfil clínico-epidemiológico de chagásicos atendidos em ambulatório de referência e proposição de modelo de atenção ao chagásico na perspectiva do sus [Clinico-epidemiologic profile of Chagas disease patients attending an ambulatory referral center and proposal of a model of care for the Chagas patient under the perspective of a comprehensive health care]. Rev Soc Bras Med Trop. 1996;29(2):101–8. Srticle in Portuguese. doi:.https://doi.org/10.1590/S0037-86821996000200002

Most read articles by the same author(s)